Variabilidad en la presentación clínica en la enfermedad de Pompe: evolución tras terapia de reemplazo enzimático

Ley Martos, Myriam; Salado Reyes, María J; Espinosa Rosso, Raúl; Solera García, Jesús; Jiménez Jiménez, Luis.
Rev. neurol. (Ed. impr.) ; 61(9): 416-420, 1 nov., 2015. graf
Artículo en Español | IBECS (España) | ID: ibc-145395

Documentos relacionados

  1. Current avenues of gene therapy in Pompe disease.
  2. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
  3. [Diagnosis and Management of Late-Onset Pompe Disease].
  4. Late Onset Pompe's Disease: Clinical, Pathological & Molecular Analysis of Two Adolescent Patients.
  5. Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening.
  6. Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know.
  7. Infantile-onset Pompe disease in seven Mexican children.
  8. Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening.
  9. Long-term outcomes of very early treated infantile-onset Pompe disease with short-term steroid premedication: experiences from a nationwide newborn screening programme.
  10. [Analysis of lysosomal enzyme activity and genetic variants in a child with late-onset Pompe disease].